相关实验视频
Updated: Sep 11, 2025
03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
528
与SUMOylation相关的基因定义了胃腺癌的预后亚型:整合单细胞分析和机器学习分析
Kaiping Luo1,2, Donghui Xing1,2, Xiang He1
1Department of Medical Oncology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Frontiers in immunology
|August 18, 2025
概括
这项研究确定了与SUMOylation相关的基因作为胃腺癌 (STAD) 风险分层的关键生物标志物. 一个新的SUMOylation风险评分 (SRS) 模型预测了患者的预后和免疫状态,帮助个性化STAD治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 胃腺癌 (STAD) 呈现出显著的分子异质性和不良预后.
- 在STAD中风险分层的生物标志物至关重要.
- 在STAD中SUMOylation的预后和免疫作用尚不清楚.
研究的目的:
- 研究STAD.中SUMOylation相关基因 (SRG) 的预后和免疫学意义.
- 在STAD中开发一个可靠的风险分层和亚型识别模型.
- 探索关键SRG在STAD进展中的功能作用.
主要方法:
- 单变Cox回归和无监督共识聚类以确定预后SRG和分子亚型.
- 使用机器学习 (随机生存森林) 开发和验证SUMOylation风险评分 (SRS) 模型.
- 免疫透,通路丰富和体外功能测试的分析.
主要成果:
- 确定了两个不同的分子亚型 (A/B),具有不同的SUMOylation模式,生存结果和免疫微环境.
- 该SRS模型实现了高预测准确性 (AUC:0.97),将患者分为高风险 (免疫抑制,晚期) 和低风险 (基因组稳定性途径) 组.
- 实验室试验证实,击败L3MBTL2和VHL促进了STAD细胞的增殖,迁移和入侵.
结论:
- 在STAD中,SRG作为独立的预后指标.
- 由SUMOylation驱动的亚型具有独特的免疫和分子特征.
- SRS模型和已识别的关键SRG (L3MBTL2,VHL) 提供了个性化的STAD管理和免疫治疗的潜力.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K